Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2021 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
IPSC on Nasdaq
Shares outstanding
181,259,081
Price per share
$0.95
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
20,280,322
Total reported value
$10,103,490
% of total 13F portfolios
0%
Share change
-2,345,667
Value change
-$1,196,912
Number of holders
53
Price from insider filings
$0.95
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RA CAPITAL MANAGEMENT, L.P. 9.9% $16,997,172 17,944,649 RA Capital Management, L.P. 09 Jan 2026
TCG Crossover GP II, LLC 9.9% $15,978,987 17,754,430 Chen Yu 09 Jan 2026
Deep Track Capital, LP 7.3% $12,137,760 13,486,400 Deep Track Capital, LP 08 Jan 2026
Venrock Healthcare Capital Partners III, L.P. 7.1% +48% $12,354,782 +$8,606,536 13,043,478 +230% Venrock Healthcare Capital Partners III, L.P. 09 Jan 2026
Commodore Capital LP 7.1% $12,354,782 13,043,478 Commodore Capital LP 09 Jan 2026
Point72 Asset Management, L.P. 5.4% $2,504,589 4,725,639 Point72 Asset Management, L.P. 23 Dec 2025
Bain Capital Life Sciences Opportunities III, LP 4.1% $1,762,227 3,538,609 Bain Capital Life Sciences Opportunities III, LP 30 Sep 2025
Casdin Capital, LLC 3.7% $1,702,527 3,212,316 Casdin Capital, LLC 31 Mar 2025

As of 30 Sep 2025, 53 institutional investors reported holding 20,280,322 shares of Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC). This represents 11% of the company’s total 181,259,081 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) together control 11% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Bain Capital Life Sciences Investors, LLC 2% 3,538,609 -35% 0.12% $1,762,227
RENAISSANCE TECHNOLOGIES LLC 1.4% 2,586,900 +28% 0% $1,288,276
VANGUARD GROUP INC 1.2% 2,103,869 -0.29% 0% $1,047,726
DAFNA Capital Management LLC 0.94% 1,704,232 0% 0.21% $848,708
Casdin Capital, LLC 0.68% 1,228,190 0% 0.05% $611,639
Syncona Portfolio Ltd 0.67% 1,213,056 0% 2.2% $604,102
TWO SIGMA INVESTMENTS, LP 0.5% 911,446 +59% 0% $453,900
TANG CAPITAL MANAGEMENT LLC 0.5% 900,000 0% 0.02% $448,200
TWO SIGMA ADVISERS, LP 0.47% 857,600 +134% 0% $427,085
MILLENNIUM MANAGEMENT LLC 0.41% 743,781 -8.4% 0% $370,403
ACADIAN ASSET MANAGEMENT LLC 0.4% 719,808 +134% 0% $357,000
GSA CAPITAL PARTNERS LLP 0.33% 603,479 +29% 0.03% $301,000
BlackRock, Inc. 0.33% 599,656 -35% 0% $298,629
SUPERSTRING CAPITAL MANAGEMENT LP 0.26% 462,963 0% 0.23% $230,556
GEODE CAPITAL MANAGEMENT, LLC 0.25% 445,309 +17% 0% $221,845
CITADEL ADVISORS LLC 0.2% 360,825 +93% 0% $179,690
Squarepoint Ops LLC 0.13% 236,053 +483% 0% $117,554
FMR LLC 0.11% 192,139 -81% 0% $95,685
STATE STREET CORP 0.07% 127,443 0% 0% $63,467
RAYMOND JAMES FINANCIAL INC 0.05% 91,323 0% 0% $45,479
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 0.04% 77,853 -4.2% 0% $43,489
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.04% 67,924 -66% 0% $33,826
NORTHERN TRUST CORP 0.04% 67,000 0% 0% $33,366
GOLDMAN SACHS GROUP INC 0.03% 60,682 -78% 0% $30,220
PRUDENTIAL FINANCIAL INC 0.03% 59,800 +32% 0% $29,780

Institutional Holders of Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 78,680 $70,895 -$50 $0.95 2
2025 Q3 20,280,322 $10,103,490 -$1,196,912 $0.50 53
2025 Q2 22,628,192 $12,642,486 -$3,582,180 $0.56 64
2025 Q1 29,565,044 $14,071,235 -$4,277,613 $0.48 69
2024 Q4 36,396,514 $36,761,199 -$7,768,598 $1.01 70
2024 Q3 39,649,193 $67,797,499 -$1,211,276 $1.71 66
2024 Q2 40,117,934 $102,301,880 +$40,961,743 $2.55 59
2024 Q1 23,113,173 $96,605,177 +$22,882,584 $4.18 66
2023 Q4 17,675,436 $58,683,678 -$543,594 $3.32 60
2023 Q3 18,060,757 $36,118,983 -$2,770,150 $2.00 53
2023 Q2 19,290,007 $60,957,915 -$2,350,461 $3.16 62
2023 Q1 20,016,851 $69,456,630 -$4,620,580 $3.47 63
2022 Q4 20,893,156 $107,178,277 -$3,631,215 $5.13 65
2022 Q3 21,098,040 $208,661,435 -$4,940,964 $9.89 52
2022 Q2 21,756,667 $182,752,181 -$3,241,178 $8.40 51
2022 Q1 22,151,698 $278,859,136 +$11,504,710 $12.59 51
2021 Q4 21,137,514 $335,200,000 +$24,348,825 $15.86 50
2021 Q3 19,798,633 $496,205,288 +$62,122,502 $25.16 47
2021 Q2 16,881,896 $490,834,435 +$490,834,432 $29.34 35